(Q83990373)
Statements
Routine upfront abciximab versus standard periprocedural therapy in patients undergoing primary percutaneous coronary intervention for cardiogenic shock: The PRAGUE-7 Study. An open randomized multicentre study (English)
Richard Rokyta
Jitka Tesarova
Jan Belohlavek